# reload+after+2024-01-23 19:27:39.697451
address1§10 Bareket Street
address2§Kiryat Matalon PO Box 7537
city§Petah Tikva
zip§4951778
country§Israel
phone§972 3 924 1114
fax§972 3 924 9378
website§https://www.canfite.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis; and Phase II clinical trial for the treatment of COVID-19. It also develops Namodenoson that is in Phase III clinical trial for the treatment of hepatocellular carcinoma, as well as in Phase IIb trial for the treatment of non-alcoholic steatohepatitis; and CF602, which is in pre-clinical trial for the treatment of erectile dysfunction. In addition, the company develops commercial predictive biomarker blood test kit for A3AR. Can-Fite BioPharma Ltd. has license and collaboration agreement with CMS Medical to develop, manufacture, and commercialize Piclidenoson and Namodenoson; and collaboration agreement with Univo Pharmaceuticals to identify and co-develop specific formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. The company was formerly known as Can-Fite Technologies Ltd. and changed its name to Can-Fite BioPharma Ltd. in January 2001. Can-Fite BioPharma Ltd. was incorporated in 1994 and is headquartered in Petah Tikva, Israel.
fullTimeEmployees§8
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Pnina  Fishman Ph.D.', 'age': 75, 'title': 'Founder, Chief Scientific Officer & Executive Chairman', 'yearBorn': 1948, 'fiscalYear': 2022, 'totalPay': 644000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Motti  Farbstein', 'age': 59, 'title': 'CEO & Chief Operating and Financial Officer', 'yearBorn': 1964, 'fiscalYear': 2022, 'totalPay': 414000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Sari  Fishman Ph.D.', 'age': 51, 'title': 'Vice President of Business Development', 'yearBorn': 1972, 'fiscalYear': 2022, 'totalPay': 325000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Ilan  Cohn Ph.D.', 'age': 69, 'title': 'Co-Founder & Director', 'yearBorn': 1954, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Stephen A.  Harrison FACP, M.D.', 'title': 'Member of Clinical Advisory Board & Consulting Chief Medical Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§0.858
priceToSalesTrailing12Months§15.905577
currency§USD
dateShortInterest§1702598400
forwardEps§-0.54
exchange§ASE
quoteType§EQUITY
shortName§Can-Fite Biopharma Ltd Sponsore
longName§Can-Fite BioPharma Ltd.
firstTradeDateEpochUtc§1352212200
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§e519a042-0611-33ca-a018-d9c27252c89f
gmtOffSetMilliseconds§-18000000
targetHighPrice§18.0
targetLowPrice§6.0
targetMeanPrice§12.0
targetMedianPrice§12.0
recommendationMean§2.0
recommendationKey§buy
numberOfAnalystOpinions§3
quickRatio§3.594
grossMargins§1.0
ebitdaMargins§0.0
trailingPegRatio§None
